Women’s Health & Wellness

Women’s Health & Wellness

The Womens Health Clinic
Kraj Stany Zjednoczone
Język EN
Odcinki 403
Najnowszy 02.08.2026

Women’s Health & Wellness is a podcast from the Women’s Health Clinic dedicated to empowering women with knowledge, support, and practical guidance on every stage of life. From reproductive health to menopause, mental wellbeing to preventive care, it breaks down stigmas and provides culturally sensitive, evidence-based insights. Experts and guests open conversations that matter, ensuring every woman feels informed, supported, and heard on her journey to better health.

Odcinki

  • How does progressive mucosal re-hydration across a laser treatment series alter real-time tissue... 02.08.2026 23min
    Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, Diagnosis, and Evidence-Based Treatments Genitourinary Syndrome of Menopause (GSM)—formerly referred to as vulvovaginal atrophy—is a chronic, progressive medical condition that affects millions of women during and after the menopausal transition. While public awareness of menopausal vasomotor symptoms (such as hot flushes and night sweats) has grown significantly, GSM...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • Can intimate exosome therapy stimulate structural extracellular matrix repair in women with... 02.08.2026 19min
    Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Diagnosis, and Evidence-Based Treatments Genitourinary Syndrome of Menopause (GSM)—formerly referred to as vulvovaginal atrophy (VVA)—is a chronic, progressive condition affecting between 50% and 70% of postmenopausal women. The term was introduced in 2014 by The International Society for the Study of Women's Sexual Health (ISSWSH) and The Menopause Society (formerly NAMS) to...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • How do clinicians manage transient micro-wheals or papules following skin booster placement in... 02.08.2026 26min
    I have created an updated patient-facing yet medically rigorous clinical guide, gsm-vulvovaginal-atrophy-guide-v2.md, which is now published in your Studio panel. This guide provides an evidence-based overview of Genitourinary Syndrome of Menopause (GSM) and vulvovaginal atrophy, explaining how sex steroid hormone depletion drives extracellular matrix breakdown, epithelial thinning, and vaginal microbiome dysbiosis. It details the full spectrum...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • How do polynucleotides signal fibroblast activation specifically in oestrogen-depleted, atrophic... 02.08.2026 21min
    Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, Diagnosis, and Advanced Regenerative Treatments For generations, women transitioning through perimenopause and menopause have been told that intimate dryness, irritation, and painful intercourse are merely inevitable, untreatable markers of getting older. Many suffer in silence due to embarrassment or a lack of awareness regarding available clinical solutions. However,...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • How does the altered thermal relaxation time of thin, dry vaginal walls affect pulse duration... 02.08.2026 22min
    I have generated the patient-facing clinical blog post on Genitourinary Syndrome of Menopause (GSM) in your Studio panel. Written in UK English, the article explains the transition from the traditional term "vaginal atrophy" to GSM, detail its anatomical and physiological causes, outlines expected clinical examination steps, and reviews evidence-based treatment options according to NICE, RCOG, and British Menopause Society (BMS) guidance. 💡...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • How do clinicians objectively assess sub-mucosal tissue density and neocollagenesis timelines... 02.08.2026 25min
    I have published an authoritative, patient-facing yet medically rigorous clinical blog post titled understanding-gsm-clinical-blog.md to your Studio panel. Summary of the Blog Post Modern Terminology & Scope: Explains why international societies transitioned from "vaginal atrophy" to Genitourinary Syndrome of Menopause (GSM) to capture the full spectrum of anatomical and functional changes affecting the vulva, vagina, urethra, and bladder. It...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • What is the risk of localised haematoma formation when performing sub-mucosal micro-droplet... 02.08.2026 25min
    Understanding Localised Haematomas: Microvascular Causes, Symptoms, and Evidence-Based Management A localised haematoma is an extravascular collection of blood that forms when an arterial, venous, or capillary wall is injured, allowing blood to escape and accumulate within surrounding soft tissue planes or body cavities. In clinical practice, purpura describes purplish cutaneous or mucosal lesions resulting from tissue hemorrhage. Lesions...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • How do mesenchymal stem cell-derived exosomes upregulate elastin and collagen gene expression in... 02.08.2026 19min
    Restoring Pelvic Floor Integrity: Understanding Pelvic Floor Dysfunction and the Promise of Exosome Therapy Pelvic floor dysfunction (PFD)—a term encompassing conditions such as pelvic organ prolapse (POP), stress urinary incontinence (SUI), and genitourinary syndrome of menopause (GSM) / vaginal atrophy—represents a major global health concern affecting approximately 40% of women over their lifetime. Despite its high prevalence, many women...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • What specific growth factor signalling cascades (VEGF, TGF-beta) does autologous PRP trigger in... 02.08.2026 18min
    Understanding Genitourinary Syndrome of Menopause (GSM): Symptoms, Causes, and Modern Treatment Options Genitourinary Syndrome of Menopause (GSM)—historically referred to as vulvovaginal atrophy (VVA) or atrophic vaginitis—is a progressive, chronic condition affecting the vulva, vagina, urethra, and bladder. While vasomotor symptoms like hot flashes often lessen over time, GSM symptoms typically persist or worsen without targeted management. ---...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • Can autologous platelet-rich fibrin (PRF) scaffolds offer longer-lasting growth factor retention... 02.08.2026 12min
    Understanding Genitourinary Syndrome of Menopause (GSM): A Comprehensive Clinical Guide to Symptoms, Causes, and Modern Treatments Genitourinary Syndrome of Menopause (GSM) is a chronic, progressive condition that affects up to 50% to 70% of postmenopausal women, as well as approximately 15% of premenopausal women experiencing hypoestrogenic states. Formally introduced in 2014 by the International Society for the Study of Women’s Sexual Health...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • How does non-ablative laser heating induce Heat Shock Protein (HSP70) expression in atrophic... 02.08.2026 22min
    Understanding Genitourinary Syndrome of Menopause (GSM): Pathophysiology, Clinical Presentation, Diagnostics, and Evidence-Based Management Genitourinary Syndrome of Menopause (GSM) is a chronic, progressive medical condition that affects over 50% of postmenopausal women. Formally defined in 2014 by a consensus panel from the International Society for the Study of Women’s Sexual Health (ISSWSH) and the North American Menopause Society (NAMS),...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • What temperature threshold limits are used during radiofrequency delivery to prevent... 02.08.2026 21min
    Navigating Genitourinary Syndrome of Menopause (GSM): Underlying Causes, Clinical Diagnosis, and Evidence-Based Treatments Genitourinary Syndrome of Menopause (GSM)—a comprehensive medical term encompassing conditions historically referred to as vulvovaginal atrophy (VVA) or atrophic vaginitis—is a chronic, progressive condition that affects up to 50% of postmenopausal women. Despite its high prevalence, GSM remains significantly underreported...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • What clinical criteria determine whether a post-cancer patient with severe atrophy should be... 02.08.2026 23min
    Understanding Genitourinary Syndrome of Menopause (GSM): Pathophysiology, Diagnostics, and Evidence-Based Management in Post-Cancer Care For many women undergoing cancer treatment or transitioning into post-cancer survivorship, physical changes in intimate health can be among the most challenging yet under-addressed aspects of recovery. Symptoms such as severe vaginal dryness, burning, loss of elasticity, and painful intercourse (dyspareunia)...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • What safety adjustments in laser fluence (J/cm^2) are necessary to prevent mucosal perforation... 02.08.2026 22min
    Understanding Genitourinary Syndrome of Menopause (GSM): Symptoms, Pathophysiology, Diagnostics, and Treatment Options What is Genitourinary Syndrome of Menopause? Genitourinary Syndrome of Menopause (GSM), previously termed vulvovaginal atrophy (VVA) or atrophic vaginitis, is a chronic, progressive medical condition caused by systemic or localized oestrogen deficiency. The term GSM was formally adopted in 2014 by the International Society for...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • What is the recommended interval between sub-mucosal polynucleotide injections and energy-based... 02.08.2026 20min
    Understanding Genitourinary Syndrome of Menopause (GSM): A Comprehensive Guide to Causes, Diagnostics, and Regenerative Therapies Genitourinary Syndrome of Menopause (GSM)—historically referred to as vulvovaginal atrophy (VVA) or atrophic vaginitis—is a chronic, progressive, and highly prevalent condition affecting between 50% and 84% of postmenopausal women. Unlike vasomotor symptoms (such as hot flushes), which often peak during the early...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • How does sub-mucosal cushioning with HA skin boosters mechanically reduce friction trauma during... 02.08.2026 21min
    Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, Diagnostic Steps, and Advanced Treatments For millions of women, the menopausal transition introduces quiet, unexpected changes to intimate health. While vasomotor symptoms like hot flushes and night sweats are widely discussed, changes in vaginal and urinary comfort often remain unmentioned due to embarrassment or the misconception that discomfort is simply an inevitable...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • How does the injection technique for uncrosslinked HA skin boosters change when treating... 02.08.2026 22min
    Understanding Genitourinary Syndrome of Menopause (GSM): Symptoms, Causes, and Modern Treatment Options Genitourinary Syndrome of Menopause (GSM)—historically termed Vulvovaginal Atrophy (VVA) or atrophic vaginitis—is a chronic, progressive hypoestrogenic condition affecting between 50% and 70% of postmenopausal women, as well as many cancer survivors undergoing anti-oestrogen therapies. Despite its high prevalence and significant impact on...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • What short-term topical pre-conditioning protocols reduce the risk of thermal blistering during... 02.08.2026 21min
    Understanding Genitourinary Syndrome of Menopause (GSM): A Patient’s Guide to Symptoms, Causes, and Evidence-Based Treatments --- What is Genitourinary Syndrome of Menopause (GSM)? For decades, the physical changes affecting the intimate areas after menopause were described simply as "vulvovaginal atrophy" (VVA). However, in 2014, leading international bodies—including the International Society for the Study of Women's Sexual Health (ISSWSH) and...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • What is the risk of local systemic spillover when using high-dose vaginal oestrogen creams... 01.08.2026 21min
    Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, and Evidence-Based Treatments Menopause is a natural biological milestone, yet many of its associated physical changes remain shrouded in silence. While vasomotor symptoms like hot flushes and night sweats are widely recognised and often ease over time, another group of symptoms affecting the intimate and urinary areas tends to persist and worsen if left unaddressed....Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.
  • Can local vaginal oestrogen be safely used long-term without routine endometrial monitoring or... 01.08.2026 18min
    Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, and Evidence-Based Treatments When people talk about menopause, hot flushes and night sweats usually dominate the conversation. However, for millions of women and individuals navigating midlife, some of the most bothersome and persistent changes happen quietly in the pelvic region. If you have experienced persistent vaginal dryness, discomfort during intimacy, an urgent...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Popularny w

Ten podcast pojawia się również w listach podcastów tych krajów.